Back to Search
JOSEFINA ROMAGUERA, MD MPH
MD MPH
Obstetrics & Gynecology Physician
NPI: 1295863843IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
7125(PR)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE
Class of 1980
Research & Publications (20)
Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.
PMID 10899497·Fertil Steril·2000
8-other
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
PMID 19581539·J Clin Oncol·2009
3-trial
Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
PMID 19170236·Cancer·2009
8-other
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
PMID 19150940·Ann Oncol·2009
8-other
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.
PMID 18779406·Blood·2008
8-other
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
PMID 18764869·Br J Haematol·2008
3-trial
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
PMID 18973182·Cancer·2008
3-trial
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
PMID 18381957·Clin Cancer Res·2008
7-preclinical
Relationship between loss of libido and signs and symptoms of depression in a sample of Puerto Rican middle-aged women.
PMID 18450239·P R Health Sci J·2008
8-other
Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
PMID 18343280·Exp Hematol·2008
8-other
Thyroid-stimulating hormone and follicle-stimulating hormone status in Hispanic women during the menopause transition.
PMID 18646355·Ethn Dis·2008
8-other
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
PMID 18223284·Haematologica·2008
3-trial
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
PMID 18085611·Cancer·2008
3-trial
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
PMID 18083690·Ann Oncol·2008
8-other
Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
PMID 17722077·Am J Hematol·2008
6-review
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.
PMID 17898787·Leukemia·2008
7-preclinical
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
PMID 17317853·Blood·2007
7-preclinical
Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.
PMID 17373675·Am J Hematol·2007
5-case
Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
PMID 18284717·Clin Lymphoma Myeloma·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- TORRE AUXIOLIO MUTUO OFICINA 614, AVE. PONCE DE LEON PARADA 37.5
SAN JUAN, PR 00917 - Phone
- (787) 274-0113
Quick Facts
- NPI
- 1295863843
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile